Nitric oxide and endothelin-1,2 in actinic keratosis and basal cell carcinoma: changes in nitric oxide/endothelin

P Vural1, D Erzengin, M Canbaz

  • 1Department of Biochemistry and Clinical Biochemistry, Istanbul Medical Faculty, Capa, Istanbul, Turkey.

Abstract

Insights

Plasma levels of nitric oxide (NOx) and endothelin-1 (ET) are elevated in skin cancer patients. The increased NOx/ET ratio in basal cell carcinoma (BCC) suggests a disturbed equilibrium contributing to tumor proliferation.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Nitric oxide (NO) exhibits cytostatic/cytotoxic effects in tumors and acts as a signaling molecule.
  • Endothelin-1 (ET-1) promotes cell proliferation and is implicated in proto-oncogene expression.
  • Both NO and ET-1 are produced by various cell types, and elevated ET-1 is linked to several cancers.

Purpose of the Study:

  • To compare plasma nitric oxide metabolites (NOx) and endothelin (ET) levels, along with the NOx/ET ratio, in patients with actinic keratosis (AK) and basal cell carcinoma (BCC) versus healthy controls.

Main Methods:

  • Plasma NOx, ET, and the NOx/ET ratio were quantified.
  • Measurements were performed in 13 AK patients, 12 BCC patients, and 16 healthy controls.

Main Results:

  • BCC patients showed significantly increased plasma NOx, ET, and NOx/ET ratios compared to controls.
  • AK patients exhibited significantly elevated plasma ET levels compared to controls.
  • The NOx/ET ratio was significantly higher in BCC patients than in AK patients.

Conclusions:

  • Elevated plasma ET and NOx in AK and BCC likely contribute to hyperkeratinization, hyperpigmentation, and keratinocyte proliferation.
  • Increased ET and NO production by keratinocytes may act as growth factors, cytotoxic agents, and mitogens, accelerating skin tumor progression.
  • The elevated NOx/ET ratio in BCC suggests an imbalance between these factors, potentially promoting cell damage and tumor growth.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...